IGF2BP2 and acute myeloid leukemia: Additionally, insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) facilitated AML development and LSCs self-renewal through regulating the expression of key targets in the glutamine metabolic pathway [23].